4.5 Review

Update on Progressive Multifocal Leukoencephalopathy

Journal

CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS
Volume 12, Issue 6, Pages 680-686

Publisher

SPRINGER
DOI: 10.1007/s11910-012-0313-4

Keywords

Progressive multifocal leukoencephalopathy; JC virus; Natalizumab; Rituximab; Efalizumab; Monoclonal antibodies

Ask authors/readers for more resources

Progressive multifocal leukoencephalopathy (PML) is a severe, often fatal, opportunistic viral infection of the central nervous system that is mainly seen in the context of AIDS and certain monoclonal immune-suppressive therapies. The causative agent, a polyoma virus, named JC virus infects only humans and there is no animal model for PML. This update focuses on information gathered in recent years on the pathogenesis of the disorder, on several clinical aspects associated with diagnosis and therapy, and on the immune reconstitution inflammatory syndrome (IRIS), a complication associated with removal of immunosuppressive therapy in PML.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available